Molecular Partners and Roche Collaborate to Develop Protein-Drug Conjugates in Oncology

By Heather Cartwright

Pharma Deals Review: Vol 2013 Issue 12 (Table of Contents)

Published: 20 Dec-2013

DOI: 10.3833/pdr.v2013.i12.1997     ISSN: 1756-7874

Section: Research & Development



Expanding the use of its DARPin® (designed ankyrin repeat proteins) biologics platform, Molecular Partners has entered into a research collaboration and licensing deal with Roche to discover, develop and commercialise multiple DARPin-drug conjugates in the field of oncology...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details